| 1 |
HURA
|
biotech
healthcare
|
TuHURA Biosciences, Inc.
|
7.0x
|
0.30
|
A niche oncology approval for IFx-2.0, paired with ex-US partnering and at least one additional validated immune-resistance asset, could turn TuHURA from a financing story into a real revenue business by 2031, but the upside only survives if runway is extended without crushing dilution.
|
| 2 |
RR
|
ai
automation
hardware
robotics
|
Richtech Robotics Inc.
|
5.8x
|
0.46
|
The upside case is not winning robotics outright; it is turning a tiny revenue base into a higher-quality recurring automation business by converting live deployments into denser RaaS fleets, better workflow embedding, and monetizable operating data before larger vendors commoditize the category.
|
| 3 |
BEAM
|
biotech
healthcare
|
Beam Therapeutics Inc.
|
5.5x
|
0.40
|
Beam can plausibly rerate from a platform-discount clinical biotech into a multi-asset rare-disease genetics company by April 2031 if risto-cel reaches market and BEAM-302 converts early human proof into an approvable liver franchise; the real edge is regulated trust, delivery, and manufacturing, not just edit design.
|
| 4 |
AISP
|
ai
cybersecurity
defense
enterprise
software
|
Airship AI Holdings, Inc.
|
5.4x
|
0.58
|
Airship AI has a plausible 5-year nonlinear upside path if it converts federal and partner demand into repeat deployments and shifts value capture from lumpy bundled systems toward sticky evidence, compliance, and support revenue embedded in sensitive workflows.
|
| 5 |
NNOX
|
ai
hardware
healthcare
medical devices
software
|
Nano-X Imaging Ltd.
|
5.1x
|
0.45
|
Nanox is a commercialization option on turning a cleared low-cost imaging device into a recurring imaging utility: if deployments become utilized, reimbursed scan volume with AI, reading, and workflow attach, the equity can rerate meaningfully from a depressed base even without a software-style premium.
|
| 6 |
NTLA
|
biotech
healthcare
|
Intellia Therapeutics, Inc.
|
4.8x
|
0.30
|
If HAELO is supportive and lonvo-z launches in 2027, Intellia can re-rate from a milestone-driven gene-editing story into a real rare-disease franchise, with HAE funding the platform and ATTR plus smarter partnering adding upside without requiring platform perfection.
|
| 7 |
RXRX
|
ai
automation
biotech
healthcare
software
|
Recursion Pharmaceuticals, Inc.
|
4.8x
|
0.60
|
At a cash-adjusted EV still dominated by proof risk, Recursion has a credible path to evolve from lumpy collaboration revenue into a higher-quality mix of product sales, milestones, royalties, and selectively externalized program vehicles if REC-4881 secures a workable regulatory path and at least one more platform-derived asset shows investable human data.
|
| 8 |
APUS
|
ai
biotech
crypto
healthcare
|
Apimeds Pharmaceuticals US, Inc.
|
4.5x
|
0.10
|
APUS is a contested micro-cap option on LT-100: if governance stabilizes, FDA feedback yields an executable Phase III plan, and management secures partner-led funding, a zero-revenue shell can rerate into a credible non-opioid pain biotech; if any one of those gates fails, dilution overwhelms the thesis.
|
| 9 |
SERV
|
ai
automation
healthcare
robotics
transportation
|
Serve Robotics Inc.
|
4.3x
|
0.64
|
Serve has a credible shot to turn a live robot fleet, major delivery-platform access, and newly acquired hospital workflows into a multi-vertical autonomy network; if utilization rises on the existing fleet and healthcare becomes recurring, revenue can scale far faster than headcount while the market still treats it as a small-cap robot operator.
|
| 10 |
MSTR
|
ai
crypto
enterprise
finance
software
|
Strategy Inc
|
4.2x
|
0.40
|
Over five years, the upside is primarily a financing-machine thesis: if Strategy keeps turning common and preferred demand into bitcoin faster than dilution while repositioning its software toward governed AI workflows, equity can compound far faster than a normal software company despite premium normalization.
|
| 11 |
DNA
|
ai
automation
biotech
cloud
healthcare
|
Ginkgo Bioworks Holdings, Inc.
|
4.1x
|
0.40
|
Post-divestiture, Ginkgo is a narrower bet that robotic lab capacity, workflow know-how, and trusted biology data can compound into a utility-like R&D infrastructure business; if utilization rises and contracts become more recurring before capital tightens, equity can still re-rate materially from a distressed base.
|
| 12 |
PRME
|
biotech
healthcare
|
Prime Medicine, Inc.
|
4.1x
|
0.28
|
Prime Medicine is a financing-constrained but genuinely differentiated editing platform: if PM359 secures a credible regulatory path and the 2026-2027 liver programs prove reusable human in vivo validation, the stock can rerate from cash-burn optionality to a multi-asset rare-disease franchise by 2031.
|
| 13 |
POET
|
ai
hardware
networking
semiconductors
|
POET Technologies Inc.
|
3.7x
|
0.60
|
POET is a well-funded, pre-scale AI optics supplier whose upside comes from converting a real photonics advantage into qualified volume production; if Malaysia ramp and partner programs turn into repeat orders, even low-single-digit share of a fast-growing interconnect stack can create multi-bagger equity value.
|
| 14 |
AI
|
ai
cloud
defense
enterprise
software
|
C3.ai, Inc.
|
3.7x
|
0.35
|
C3 AI is a battered but real enterprise-AI vendor: if the reset restores conversion and it shifts value capture toward trusted, regulated, outcome-linked workflows, revenue can roughly triple by 2031; if not, the workflow layer gets bundled and pricing compresses.
|
| 15 |
QUBT
|
ai
communications
hardware
quantum
semiconductors
|
Quantum Computing Inc.
|
3.7x
|
0.55
|
QCi is a commercialization bet on scarce U.S. photonics capacity: if it turns Fab 1, packaged components, and Quantum Corridor access into repeat orders, it can graduate from a near-zero-revenue quantum story into a niche AI and communications infrastructure supplier; if not, valuation gravity wins.
|
| 16 |
SDGR
|
ai
biotech
enterprise
healthcare
software
|
Schrödinger, Inc.
|
3.6x
|
0.55
|
Schrödinger can create solid 5-year equity upside if it turns embedded discovery software into a cleaner hosted workflow system with durable ACV growth, adds higher-value modules like predictive toxicology, and externalizes most clinical spend through partners so pipeline upside remains option value rather than a balance-sheet drag.
|
| 17 |
MBLY
|
ai
automation
automotive
semiconductors
software
|
Mobileye Global Inc.
|
3.6x
|
0.68
|
Mobileye is a leveraged way to own rising AI content per vehicle: if it converts its installed base, validation know-how, and road-data edge into mass-market advanced systems, revenue can compound well above auto production without needing robotaxi to carry the full case.
|
| 18 |
AUR
|
ai
automation
robotics
software
transportation
|
Aurora Innovation, Inc.
|
3.6x
|
0.60
|
Aurora can turn a narrow first-mover lead in driverless trucking into a denser Sun Belt freight network and higher-value workflow surface, but the equity only compounds if 2026 proves observer-free launch, truck supply, and lane expansion are repeatable rather than bespoke.
|
| 19 |
ACHR
|
aerospace
automation
defense
evtol
transportation
|
Archer Aviation Inc.
|
3.5x
|
0.58
|
Archer can create multi-bagger value not by instantly building a mass air-taxi network, but by becoming one of the few certified Western eVTOL platforms and then widening capture into fleet availability, training, powertrain, defense and regulated operating software around Midnight.
|
| 20 |
PDYN
|
aerospace
ai
automation
defense
software
|
Palladyne AI Corp.
|
3.5x
|
0.60
|
If Palladyne converts early defense validation into a certified OEM network, retrofit programs, and recurring autonomy assurance revenue, its tiny base can scale into a real defense-autonomy platform; the upside comes from owning trusted embedded workflow positions, not from selling generic AI seats.
|
| 21 |
CRSP
|
ai
biotech
healthcare
|
CRISPR Therapeutics AG
|
3.4x
|
0.40
|
CRSP already has real CRISPR-medicine proof and a balance sheet that can fund multiple shots on goal; if CASGEVY keeps scaling and one wholly owned program becomes a credible second franchise, the stock can rerate from cash-backed optionality into a multi-asset gene-editing company.
|
| 22 |
RLAY
|
ai
biotech
healthcare
|
Relay Therapeutics, Inc.
|
3.3x
|
0.40
|
Relay is a clinical-proof story, not a software story: if zovegalisib converts strong early data into a registrational win and Relay builds testing, access, and evidence rails around launch, the company can turn a narrow license-revenue profile into a real precision-oncology franchise with rare-disease upside by 2031.
|
| 23 |
INOD
|
ai
enterprise
healthcare
software
|
Innodata Inc.
|
3.3x
|
0.45
|
Innodata can outgrow the market if it converts today’s frontier-AI data and evaluation demand into a stickier trust layer for regulated, enterprise, and federal workflows; the upside is real, but durable value requires lower customer concentration and better capture than project labor alone.
|
| 24 |
QBTS
|
cloud
enterprise
hardware
quantum
software
|
D-Wave Quantum Inc.
|
3.2x
|
0.45
|
D-Wave can still become a much larger business if it converts its annealing lead, cloud stack, and new gate-model option into repeatable production optimization revenue, but the stock already discounts a meaningful platform outcome, so the next five years are about commercial proof more than scientific headlines.
|
| 25 |
IONQ
|
cloud
defense
hardware
networking
quantum
|
IonQ, Inc.
|
3.1x
|
0.60
|
IonQ can grow from a premium narrative stock into a strategic quantum infrastructure vendor if it turns trapped-ion performance, trusted manufacturing, and government-grade distribution into reserved capacity, system sales, and workflow control before broader quantum utility becomes obvious; that can still create a multi-bagger, but execution now matters far more than storytelling.
|
| 26 |
SMR
|
automation
energy
hardware
nuclear
|
NuScale Power Corporation
|
3.1x
|
0.65
|
NuScale is a leveraged bet that AI-driven power scarcity makes a scarce NRC-approved SMR design far more valuable than current revenue implies; if it converts one flagship ENTRA1-led or RoPower pathway into a bankable reference plant, licensing, module, fuel, and service revenue can inflect sharply by 2031, though dilution and partner dependence cap the upside.
|
| 27 |
OUST
|
ai
automation
hardware
robotics
software
|
Ouster, Inc.
|
3.1x
|
0.50
|
Ouster can create meaningful value if it turns lidar-plus-camera deployments into workflow-embedded perception contracts, letting software attach and partner distribution lift revenue faster than sensor pricing compresses it.
|
| 28 |
ESTC
|
ai
cloud
cybersecurity
enterprise
software
|
Elastic N.V.
|
3.1x
|
0.55
|
Elastic is a discounted AI-era context layer: if it converts embedded search, observability, and security usage into durable workflow control, regulated wins, and broader cloud commitments, revenue can more than double by 2031 and the stock can compound at a mid-20s rate without needing a best-in-class software multiple.
|
| 29 |
IREN
|
ai
cloud
crypto
energy
hardware
|
IREN Limited
|
3.1x
|
0.76
|
IREN’s best 5-year outcome comes from turning scarce grid-connected campuses into contracted AI infrastructure faster than dilution, GPU delivery risk and pricing resets erode per-share value; if it keeps financing disciplined, it can compound as an AI-capacity developer rather than remain a miner hybrid.
|
| 30 |
RDVT
|
ai
enterprise
finance
software
|
Red Violet, Inc.
|
3.0x
|
0.60
|
RDVT is a small-cap, usage-led identity intelligence company whose core asset is not a thin software wrapper but a data-and-workflow control point; if AI drives more onboarding, fraud, collections, and trust decisions into automated workflows, RDVT can grow query volume and move up-stack into decision-grade outputs, provided data rights and privacy constraints stay manageable.
|
| 31 |
NBIS
|
ai
cloud
enterprise
hardware
software
|
Nebius Group N.V.
|
3.0x
|
0.78
|
Nebius is a leveraged owner-operator of scarce AI capacity: if it converts financed power, NVIDIA supply and anchor contracts into live, highly utilized clusters while adding trust and workflow software, revenue can scale non-linearly; the stock does not need heroic rerating, but it does require unusually clean physical execution.
|
| 32 |
SMCI
|
ai
cloud
enterprise
hardware
|
Super Micro Computer, Inc.
|
2.9x
|
0.58
|
Supermicro can still create outsized value if it remains the fastest way to get dense AI racks online and gradually shifts capture from pure box margin toward integrated deployment, liquid cooling, compliance, and lifecycle services; it does not need a software multiple, but it does need trust repair and better cash conversion.
|
| 33 |
BFLY
|
ai
hardware
healthcare
medical devices
software
|
Butterfly Network, Inc.
|
2.8x
|
0.50
|
Butterfly has a credible path from niche handheld-ultrasound vendor to a regulated imaging platform with higher-value software, compliance, and embedded licensing layers; if it converts HomeCare, enterprise workflow, and partner APIs into repeatable revenue, the stock can compound above normal medtech rates without needing a heroic software rerating.
|
| 34 |
COIN
|
ai
crypto
enterprise
finance
software
|
Coinbase Global, Inc.
|
2.8x
|
0.60
|
Coinbase can compound from a cyclical crypto broker into a trusted execution, custody, stablecoin, and agent-ready financial operating layer; if USDC, derivatives, payments, Base, and cross-asset workflows scale together, revenue can roughly triple by 2031 even with lower spot-fee dependence.
|
| 35 |
JOBY
|
aerospace
defense
evtol
transportation
|
Joby Aviation, Inc.
|
2.8x
|
0.62
|
Over five years, Joby can turn a rare certification-and-manufacturing lead into a multi-surface mobility business across premium airport transfers, aircraft sales, and recurring operating infrastructure; the upside is real, but shareholder value depends on converting technical progress into dense, reliable commercial utilization before dilution eats too much of the prize.
|
| 36 |
SPIR
|
aerospace
defense
software
space
|
Spire Global, Inc.
|
2.8x
|
0.60
|
Spire’s best 5-year path is not becoming a pure software winner; it is becoming a more trusted orbital data and mission-infrastructure asset, where weather, defense RF, and sovereign space services scale off the same constellation and move value capture from raw feeds toward verified, embedded, higher-consequence workflows.
|
| 37 |
PATH
|
ai
automation
cloud
enterprise
software
|
UiPath, Inc.
|
2.8x
|
0.40
|
UiPath can turn its installed RPA base into a governed execution layer for enterprise agents; if AI attach, vertical solutions, and pricing shift toward workflow outcomes, revenue can reaccelerate enough to drive a 2-3x equity outcome from a still-depressed starting valuation.
|
| 38 |
FLNC
|
automation
energy
enterprise
software
|
Fluence Energy, Inc.
|
2.7x
|
0.56
|
Fluence can roughly triple equity value by 2031 if it turns covered backlog into repeatable delivery, uses domestic-content positioning to keep winning U.S. projects, and lifts software and service mix enough that investors stop valuing it as a thin-margin storage integrator.
|
| 39 |
AMBA
|
ai
automotive
hardware
robotics
semiconductors
|
Ambarella, Inc.
|
2.7x
|
0.60
|
Ambarella is a real edge-AI silicon supplier whose upside comes from converting design wins into shipping CV72, CV75, CV7 and newer product volume across security, auto and robotics; if it adds stickier deployment and trust tooling on top of its low-power chips, revenue can roughly triple by 2031, though foundry dependence and distributor concentration cap how much AI value it keeps.
|
| 40 |
S
|
ai
cloud
cybersecurity
enterprise
software
|
SentinelOne, Inc.
|
2.7x
|
0.60
|
SentinelOne has a realistic path to more than double revenue by turning endpoint landings into a broader AI-native security control layer across cloud, identity, data, and automated response, but the upside depends on proving that newer modules become durable budget owners before larger suites compress pricing.
|
| 41 |
SOUN
|
ai
automation
automotive
enterprise
software
|
SoundHound AI, Inc.
|
2.7x
|
0.40
|
SoundHound can grow into a materially larger multi-vertical voice-and-agent software company if it converts recent deployments into recurring production revenue, shifts some value capture toward outcomes or transactions, and fixes governance fast enough to keep enterprise trust and access to capital intact.
|
| 42 |
ZS
|
cloud
cybersecurity
enterprise
networking
software
|
Zscaler, Inc.
|
2.7x
|
0.68
|
Zscaler should outgrow mature software because its inline control plane can expand from securing employees to securing workloads, data, branches and AI agents; if it keeps shifting pricing toward usage and converts trust/compliance advantages into larger platform deals, 2031 revenue can reach 8000 without needing a speculative valuation.
|
| 43 |
NOW
|
ai
automation
cloud
enterprise
software
|
ServiceNow, Inc.
|
2.6x
|
0.70
|
ServiceNow can remain a premium compounder by turning its installed workflow base into the trusted execution, verification, and governance layer for enterprise AI; if pricing evolves from seats toward workflow outcomes and regulated automation, revenue can reach the mid-30 billions by 2031 without needing a euphoric multiple.
|
| 44 |
TEM
|
ai
biotech
enterprise
healthcare
software
|
Tempus AI, Inc.
|
2.6x
|
0.68
|
Tempus can compound into a meaningfully larger healthcare AI platform if it turns its diagnostics-fed data rights and physician workflow footprint into recurring evidence, software, and operating-layer revenue while proving that growth no longer depends on external capital.
|
| 45 |
ALAB
|
ai
cloud
hardware
networking
semiconductors
|
Astera Labs, Inc.
|
2.6x
|
0.66
|
Astera is well placed to turn AI rack complexity into higher content per deployment by expanding from retimers into switches, modules, custom connectivity and workflow software, but the equity only compounds hard if Scorpio X broadens beyond a lead customer and concentration falls.
|
| 46 |
CRDO
|
ai
hardware
networking
semiconductors
|
Credo Technology Group Holding Ltd
|
2.5x
|
0.66
|
Credo is a real AI interconnect winner, but the five-year upside now depends on broadening a reliability-led foothold in AECs into a fuller stack across optics, DSPs, retimers, IP, and assurance software; that can still support a little over 2x equity value from here even if the valuation multiple compresses.
|
| 47 |
CRWV
|
ai
cloud
enterprise
software
|
CoreWeave, Inc.
|
2.5x
|
0.76
|
CoreWeave can still compound strongly if it keeps converting signed AI demand into energized capacity faster than peers, lowers its cost of capital through contract-backed financing, and gradually moves part of value capture from raw compute into higher-trust software, runtime, and embedded distribution.
|
| 48 |
LMND
|
ai
automotive
finance
software
|
Lemonade, Inc.
|
2.5x
|
0.60
|
Lemonade can still roughly double to triple equity value by 2031 if its AI-native carrier stack turns Car, multi-policy households, and Europe into durable underwriting gains and lower acquisition cost; the win condition is becoming a premium insurer with regulated data and workflow advantages, not keeping a software-style multiple forever.
|
| 49 |
RCAT
|
aerospace
automation
defense
hardware
robotics
|
Red Cat Holdings, Inc.
|
2.5x
|
0.60
|
Red Cat is a real AI-era defense beneficiary because trusted domestic drones, maritime robots, and workflow software should see rising demand, but shareholder upside depends on converting that demand into diversified deliveries, better gross margins, and some recurring readiness revenue before today's premium valuation compresses the payoff.
|
| 50 |
APLD
|
ai
cloud
crypto
energy
hardware
|
Applied Digital Corporation
|
2.5x
|
0.64
|
Applied Digital can still roughly double equity value by 2031 if it converts scarce power access into repeatable long-duration AI campus rent, uses live assets to lower its cost of capital, and adds modest fee-style upside from asset recycling; the opportunity is real, but future gains now depend more on energizing MW than on narrative rerating.
|
| 51 |
CORZ
|
ai
cloud
crypto
energy
hardware
|
Core Scientific, Inc.
|
2.4x
|
0.64
|
Core Scientific can turn a low-margin mining footprint into scarce AI infrastructure if it converts powered campuses into billable colocation fast, diversifies beyond one tenant, and keeps financing from overwhelming the equity story; that mix shift can support a meaningful but not pure-play rerate by 2031.
|
| 52 |
FIVN
|
ai
cloud
communications
enterprise
software
|
Five9, Inc.
|
2.4x
|
0.40
|
Five9 is a mispriced cloud contact-center workflow layer: if it shifts monetization from seat-heavy bundles toward AI orchestration, usage, trust, and partner-led distribution faster than automation shrinks agent seats, it can sustain low-teens revenue growth and deliver outsized equity upside from a depressed valuation.
|
| 53 |
OKLO
|
ai
energy
nuclear
|
Oklo Inc.
|
2.4x
|
0.70
|
Oklo is a scarce AI-power option on permissioned nuclear capacity: if it turns Idaho into operating proof and converts Ohio into an executable campus, the company can rerate from pre-revenue developer to repeatable clean-power platform, with isotopes and fuel services adding upside and smarter project finance limiting dilution.
|
| 54 |
RGTI
|
cloud
enterprise
hardware
quantum
|
Rigetti Computing, Inc.
|
2.4x
|
0.43
|
An integrated superconducting quantum stack with an in-house fab gives this business a real chance to turn sovereign, research, and hybrid compute demand into a niche infrastructure franchise by 2031, but only if 108-qubit systems keep improving in fidelity and recent orders become repeatable recurring revenue rather than isolated science projects.
|
| 55 |
BBAI
|
ai
defense
enterprise
software
transportation
|
BigBear.ai Holdings, Inc.
|
2.3x
|
0.40
|
BigBear.ai is a small-cap bet that secure government AI shifts from lumpy project work to repeatable workflow software. If Ask Sage and CargoSeer become embedded trust layers rather than token-priced wrappers, revenue can roughly triple by 2031 and enterprise value can double-plus; if not, dilution and contractor-style economics will dominate.
|
| 56 |
WULF
|
ai
cloud
crypto
energy
|
TeraWulf Inc.
|
2.3x
|
0.68
|
TeraWulf can compound by turning scarce power-backed campuses and credit-enhanced AI leases into a repeatable development-and-finance machine; the upside is real if 2026 deliveries unlock a larger multi-campus build cycle, but value capture depends more on execution and funding than on demand.
|
| 57 |
DDOG
|
ai
cloud
cybersecurity
enterprise
software
|
Datadog, Inc.
|
2.3x
|
0.60
|
AI makes software systems noisier, more security-sensitive, and more automated; if Datadog keeps converting telemetry presence into security, workflow, and governed agent spend, revenue can roughly triple by 2031 even if raw ingest pricing gets tougher.
|
| 58 |
ASTS
|
aerospace
communications
defense
networking
space
|
AST SpaceMobile, Inc.
|
2.3x
|
0.60
|
AST can still create strong equity value if it becomes the carrier-embedded default layer for always-available mobile coverage, but from today the upside depends far more on proving repeatable launches, approvals, and monetization than on proving the core radio concept.
|
| 59 |
RIOT
|
ai
cloud
crypto
energy
hardware
|
Riot Platforms, Inc.
|
2.3x
|
0.60
|
Riot's upside is not from winning bitcoin mining alone; it is from proving that its already-approved Texas power and in-house electrical stack can be repeatedly converted into long-duration AI infrastructure revenue, lifting the business from spread-driven miner economics toward contracted digital infrastructure economics.
|
| 60 |
APP
|
advertising
ai
media
software
|
AppLovin Corporation
|
2.3x
|
0.65
|
AppLovin can turn an elite mobile-gaming ad engine into a broader performance-commerce network; if self-serve e-commerce, web demand, measurement, and connected-TV scale, revenue can more than triple by 2031 even with multiple compression, because it sells measurable outcomes rather than seats and converts incremental revenue into cash unusually well.
|
| 61 |
HUT
|
ai
cloud
crypto
energy
enterprise
|
Hut 8 Corp.
|
2.3x
|
0.62
|
Hut 8 can roughly double equity value by 2031 if River Bend becomes the first proof point in a repeatable power-to-AI-campus playbook, because scarce powered sites and long-duration contracted capacity should matter more than standalone mining in the AI era; the rerating only sticks if growth is funded mainly with project capital rather than repeated common-equity issuance.
|
| 62 |
SNOW
|
ai
cloud
enterprise
software
|
Snowflake Inc.
|
2.3x
|
0.65
|
Snowflake can compound well above software-market norms if AI drives far more governed queries, pipelines, and agent actions onto trusted enterprise data, but the likely payoff is a durable 2x-3x equity outcome rather than true hypergrowth because hyperscalers and open formats cap terminal pricing power.
|
| 63 |
KTOS
|
aerospace
defense
hardware
software
space
|
Kratos Defense & Security Solutions, Inc.
|
2.2x
|
0.60
|
Kratos is one of the few public equities positioned at the intersection of affordable autonomous mass, propulsion, microwave defense electronics, and space-ground orchestration; if funded development programs convert into repeat production and trusted workflow software, revenue can compound hard enough to overcome a still-premium starting valuation.
|
| 64 |
AMPX
|
aerospace
defense
energy
hardware
transportation
|
Amprius Technologies, Inc.
|
2.2x
|
0.50
|
Amprius can still roughly double equity value by 2031 if SiCore moves from impressive qualifications to routine, profitable shipments: AI-era drones, defense systems, and light mobility widen demand for lighter batteries, while the partner-led model can keep capex manageable. The stock is already expensive, so the win condition is volume conversion and margin control, not more announcements alone.
|
| 65 |
AVAV
|
aerospace
defense
robotics
software
space
|
AeroVironment, Inc.
|
2.2x
|
0.68
|
AeroVironment can roughly double equity value by 2031 if it converts today’s autonomy and munition demand into repeat production, expands allied distribution, and lifts software and sustainment attach without needing pure-software economics.
|
| 66 |
CRNC
|
ai
automotive
cloud
software
|
Cerence Inc.
|
2.2x
|
0.40
|
Cerence is a low-multiple embedded automotive AI supplier with real distribution; if 2026 xUI launches become on-road proof and the company shifts value capture from legacy royalties toward higher-content connected, trust, and action workflows, the stock can rerate into a credible 2-3x equity outcome by 2031 without needing heroic market-share assumptions.
|
| 67 |
RKLB
|
aerospace
defense
hardware
space
|
Rocket Lab Corporation
|
2.2x
|
0.64
|
Rocket Lab is becoming a scarce space-and-defense capacity owner rather than just a small-launch vendor; if Neutron enters service and the company turns launch, spacecraft, components, and sustainment into a repeatable stack, revenue can scale non-linearly, but today’s valuation already prices in a large part of that success.
|
| 68 |
AMD
|
ai
cloud
enterprise
hardware
semiconductors
|
Advanced Micro Devices, Inc.
|
2.2x
|
0.60
|
AMD can still create strong equity value through 2031 by pairing server CPU share gains with a credible No. 2 position in AI accelerators and rack-scale systems; the bull case is not monopoly dominance, but durable second-source status that compounds through hyperscaler, sovereign and enterprise AI deployments.
|
| 69 |
CLS
|
ai
cloud
communications
hardware
networking
|
Celestica Inc.
|
2.2x
|
0.62
|
Celestica can roughly double equity value by 2031 if it converts today’s hyperscaler AI ramps into a broader, stickier data-center manufacturing franchise: qualified capacity, rack integration and process know-how matter more in an AI capex boom, and the market does not need to award software-like multiples for that to work.
|
| 70 |
TWST
|
automation
biotech
healthcare
|
Twist Bioscience Corporation
|
2.2x
|
0.50
|
As AI makes biological design cheaper, more value shifts to trusted physical execution. Twist can turn its silicon-based DNA manufacturing, workflow embedment, and compliance layer into a broader biology infrastructure business if it sustains volume growth, keeps gross margin above 50%, and reaches the promised FY26 breakeven inflection.
|
| 71 |
SYM
|
ai
automation
enterprise
robotics
software
|
Symbotic Inc.
|
2.1x
|
0.67
|
Symbotic can convert a massive contracted backlog into a far larger installed base and richer recurring service stream as AI makes warehouse labor and coordination more valuable to automate, but the stock’s upside still depends on proving it is more than a Walmart-shaped project business.
|
| 72 |
LSCC
|
ai
automation
cybersecurity
hardware
semiconductors
|
Lattice Semiconductor Corporation
|
2.1x
|
0.60
|
Lattice is a premium niche semiconductor franchise that can outgrow most small-cap semis as AI servers, secure control, and physical-AI systems need more low-power programmable logic; the key is turning design wins and richer new-product mix into durable production revenue before fixed-function silicon compresses the socket.
|
| 73 |
META
|
advertising
ai
communications
hardware
media
|
Meta Platforms, Inc.
|
2.1x
|
0.78
|
Meta is a rare mega-cap where AI can improve the core business immediately: better ranking, creative and attribution raise advertiser ROI on owned surfaces, while WhatsApp workflows, Threads, Meta AI and glasses add adjacent monetization. The upside is strong compounding from an existing machine, not a reinvention.
|
| 74 |
MRVL
|
ai
cloud
hardware
networking
semiconductors
|
Marvell Technology, Inc.
|
2.1x
|
0.68
|
Marvell can turn qualified AI sockets in custom silicon, optics and cluster connectivity into a much larger revenue base by 2031, but the stock only works if design wins convert into shipped volume faster than supplier bottlenecks, customer insourcing and valuation compression offset the growth.
|
| 75 |
RMBS
|
ai
cybersecurity
hardware
semiconductors
|
Rambus Inc.
|
2.1x
|
0.62
|
Rambus is an asset-light way to own AI memory bottlenecks: if it converts DDR5, HBM4E, MRDIMM and security design-ins into sustained chips, royalties and workflow control, revenue can more than double by 2031 while margins remain strong enough to support a still-premium multiple.
|
| 76 |
NTRA
|
ai
biotech
healthcare
medical devices
|
Natera, Inc.
|
2.1x
|
0.65
|
Natera can compound into a much larger oncology-centered precision-medicine franchise if Signatera keeps converting clinical evidence into covered reimbursement, workflow embedment, and companion-diagnostic relevance, while women’s health and organ health fund execution; the upside is real, but future returns depend on defending premium value capture as MRD becomes more standard.
|
| 77 |
ORCL
|
ai
automation
cloud
enterprise
software
|
Oracle Corporation
|
2.1x
|
0.78
|
Oracle is one of the few incumbents that can monetize both sides of the AI stack—trusted systems of record and scarce cloud capacity—so if it converts backlog into live OCI usage without letting capex outrun returns, it can more than double equity value by 2031 from mega-cap scale.
|
| 78 |
PANW
|
ai
cloud
cybersecurity
enterprise
software
|
Palo Alto Networks, Inc.
|
2.0x
|
0.70
|
Palo Alto Networks can still plausibly compound into a roughly 2x equity outcome by 2031 because AI expands the attack surface, identity sprawl, and need for verified automation, while PANW already controls multiple enterprise security checkpoints and can deepen wallet share through platformization, CyberArk, browser, observability, and AI-security layers.
|
| 79 |
VICR
|
ai
defense
hardware
networking
semiconductors
|
Vicor Corporation
|
2.0x
|
0.60
|
Vicor is a real AI power bottleneck, not an AI wrapper: if it converts design wins into qualified volume, expands capacity, and makes licensing more repeatable, revenue can scale sharply by 2031. But the stock already discounts a large slice of that future, so business upside is more dramatic than likely shareholder upside.
|
| 80 |
SITM
|
ai
communications
hardware
networking
semiconductors
|
SiTime Corporation
|
2.0x
|
0.55
|
SiTime is a scarce pure-play timing supplier whose value can compound non-linearly if AI/datacenter synchronization demand stays strong and the Renesas acquisition turns it from a premium component vendor into a broader clocking franchise; the key caveat is that much of the scarcity premium is already in the stock.
|
| 81 |
ARM
|
ai
cloud
hardware
semiconductors
|
Arm Holdings plc
|
2.0x
|
0.80
|
Arm is a high-quality AI architecture tollbooth: if it keeps converting cloud CPU share gains, Armv9/CSS mix, and selective first-party silicon into richer royalty dollars per design win, revenue can compound far faster than the broader chip market even as the valuation multiple cools from today’s premium.
|
| 82 |
MSFT
|
ai
cloud
cybersecurity
enterprise
software
|
Microsoft Corporation
|
2.0x
|
0.84
|
Microsoft can keep compounding by monetizing AI at three layers at once: Azure runtime, enterprise control and trust, and the daily workflow surface inside Microsoft 365 and GitHub. If power and datacenter buildout keep pace, value capture should shift from seats alone toward higher-yield usage, governance, and workflow revenue rather than leaking out of the stack.
|
| 83 |
BKSY
|
aerospace
ai
defense
software
space
|
BlackSky Technology Inc.
|
2.0x
|
0.70
|
BlackSky can become a better recurring defense-intelligence business as Gen-3 capacity, Assured subscriptions, and standardized sovereign programs turn scarce orbital access into workflow revenue, but the stock already discounts a lot of that improvement, so business upside should exceed equity upside.
|
| 84 |
NVDA
|
ai
hardware
networking
semiconductors
software
|
NVIDIA Corporation
|
2.0x
|
0.95
|
Over the next five years, NVIDIA can still compound from a huge base because it owns the default AI-factory stack across chips, networking, systems and deployment software; the nonlinear upside is not just selling more accelerators, but capturing more of each data-center build through rack-scale systems, sovereign infrastructure and trusted control layers as AI becomes national and industrial infrastructure.
|
| 85 |
PL
|
aerospace
defense
software
space
|
Planet Labs PBC
|
2.0x
|
0.70
|
Planet owns a scarce orbital data-rights asset that should become more valuable as AI makes Earth imagery easier to use inside real workflows, but most remaining equity upside now depends on converting backlog into sovereign, satellite-services, and trust-heavy products rather than on another narrative rerating.
|
| 86 |
TSM
|
ai
hardware
semiconductors
|
Taiwan Semiconductor Manufacturing Company Limited
|
2.0x
|
0.90
|
TSMC remains the highest-quality physical bottleneck in AI: if it converts N2 and advanced-packaging scarcity into shipped output and better capacity monetization, revenue can more than double by 2031, but the stock likely compounds in the low teens because much of that strategic value is already recognized.
|
| 87 |
COHR
|
ai
communications
hardware
networking
semiconductors
|
Coherent Corp.
|
1.9x
|
0.77
|
Coherent is a real AI-infrastructure bottleneck: if it converts scarce, qualified photonics capacity into multi-year design wins, better mix, and cleaner cash generation, revenue can roughly double by 2031; the cap is that this is still a capital-intensive component business selling to a few powerful buyers.
|
| 88 |
FN
|
automation
communications
hardware
networking
|
Fabrinet
|
1.9x
|
0.60
|
Fabrinet can still roughly double enterprise value by 2031 if new Thailand capacity fills with harder-to-build AI interconnect and photonics programs, yields stay strong, and the company captures more value through scarce qualified capacity and lifecycle service layers rather than pure build-price labor.
|
| 89 |
ANET
|
ai
cloud
hardware
networking
software
|
Arista Networks, Inc.
|
1.9x
|
0.74
|
Arista is one of the cleanest ways to own AI-era Ethernet scaling: it has proven hardware execution, a sticky EOS and CloudVision operating model, and room to expand from AI fabrics into campus, routing, WAN, and higher-value assurance software, but the stock already prices in much of that quality.
|
| 90 |
AVGO
|
ai
cloud
networking
semiconductors
software
|
Broadcom Inc.
|
1.9x
|
0.80
|
Broadcom is one of the few companies that can turn hyperscaler AI roadmaps into shipped custom silicon, Ethernet fabrics, and private-cloud control software at massive scale; if it preserves scarcity pricing and VMware durability, revenue can roughly double by 2031 even from a very large base.
|
| 91 |
CDNS
|
ai
enterprise
hardware
semiconductors
software
|
Cadence Design Systems, Inc.
|
1.9x
|
0.78
|
Cadence should keep compounding as AI increases chip and system complexity, pushing more value into trusted signoff, verification, IP, emulation, and system-analysis workflows that are deeply embedded and hard to replace.
|
| 92 |
DELL
|
ai
cloud
enterprise
hardware
networking
|
Dell Technologies Inc.
|
1.9x
|
0.60
|
Dell can turn record AI demand into a stronger, more repeatable infrastructure franchise by being the financed deployment, storage and lifecycle layer enterprises trust when AI moves from pilots to production. If backlog converts with acceptable margins and richer attach, the stock can compound at a mid-teens rate through 2031 without requiring software-style valuation.
|
| 93 |
JBL
|
ai
automation
cloud
hardware
healthcare
|
Jabil Inc.
|
1.9x
|
0.60
|
Jabil can compound value by proving it is not just a generic contract manufacturer but a scaled AI infrastructure integrator in racks, power, liquid cooling, and regulated builds; if that mix keeps lifting cash flow and buybacks, roughly 2x enterprise value by 2031 is plausible without heroic market-share gains.
|
| 94 |
MU
|
ai
cloud
enterprise
hardware
semiconductors
|
Micron Technology, Inc.
|
1.9x
|
0.78
|
Micron is one of the few mega-cap AI infrastructure names whose control point is still physical scarcity: qualified memory and packaging capacity. If it converts today’s shortage into deeper design-ins, higher-value content and longer contracts, revenue can remain structurally above prior memory cycles, though its size and capex needs likely cap upside below software-like hypergrowth.
|
| 95 |
AMZN
|
advertising
ai
cloud
communications
transportation
|
Amazon.com, Inc.
|
1.9x
|
0.82
|
Amazon can still roughly double equity value by 2031 if AWS converts today's AI capacity shortage into durable high-margin usage while ads, seller services, and fulfillment automation keep lifting mix; the upside comes less from heroic revenue assumptions than from turning huge capex into trusted compute and transaction tollbooths.
|
| 96 |
PLTR
|
ai
cloud
defense
enterprise
software
|
Palantir Technologies Inc.
|
1.9x
|
0.75
|
Palantir can keep compounding as the trusted operating layer for production AI in defense and regulated enterprises, but from this valuation the next leg of shareholder return depends on repeatable account expansion and higher-value trust-governance monetization, not just AI scarcity hype.
|
| 97 |
MPWR
|
ai
automotive
enterprise
hardware
semiconductors
|
Monolithic Power Systems, Inc.
|
1.9x
|
0.61
|
MPS is a high-quality power compounder for the AI-and-electrification buildout: if it keeps converting data-center sockets, raises module content, and layers trusted design and qualification workflows onto its silicon, revenue can more than double by 2031; but with the stock already premium, shareholder upside depends more on execution than rerating.
|
| 98 |
SNPS
|
ai
automation
cloud
semiconductors
software
|
Synopsys, Inc.
|
1.9x
|
0.75
|
Synopsys is an AI-era toll collector for engineering complexity: as chips and intelligent systems get harder to design and validate, customers consolidate around deeper, trusted workflows. If the Ansys combination converts into real cross-sell and Design IP execution normalizes, Synopsys can still deliver a solid 5-year equity double from a reset base.
|
| 99 |
TSLA
|
ai
automotive
energy
robotics
transportation
|
Tesla, Inc.
|
1.9x
|
0.65
|
Tesla can still compound revenue meaningfully by turning its installed base, battery footprint, charging network and customer account control into a larger energy-and-autonomy stack, but the stock’s upside now depends less on selling more cars and more on proving that software, energy services and regulated autonomy become a bigger share of economics by 2031.
|
| 100 |
CRM
|
ai
automation
cloud
enterprise
software
|
Salesforce, Inc.
|
1.9x
|
0.65
|
Salesforce should capture AI value not by owning frontier models but by owning the enterprise workflow, data, permissions, and billing surfaces where agents do real work; if Agentforce, Data Cloud, Slack, and Informatica convert usage into durable revenue while buybacks shrink the share base, the stock can plausibly compound near 2x by April 2031 without needing peak-SaaS exuberance.
|
| 101 |
ON
|
ai
automation
automotive
hardware
semiconductors
|
ON Semiconductor Corporation
|
1.8x
|
0.60
|
onsemi is a qualified power-and-sensing franchise coming out of a cyclical trough; if it restores fab loading and keeps shifting mix toward harder-to-replace automotive, energy, and AI-power sockets, revenue can compound meaningfully and the stock can rerate modestly, though it is unlikely to earn the scarcity multiple of a true compute bottleneck.
|
| 102 |
AAOI
|
ai
communications
hardware
networking
semiconductors
|
Applied Optoelectronics, Inc.
|
1.8x
|
0.60
|
AOI has real non-linear revenue optionality because AI clusters need ever-faster optical links and AOI controls qualified laser-to-transceiver capacity, but from today’s valuation the investment case depends on converting 800G and 1.6T orders into high-yield, low-dilution scale rather than on another speculative rerating.
|
| 103 |
MTSI
|
communications
defense
networking
semiconductors
space
|
MACOM Technology Solutions Holdings, Inc.
|
1.8x
|
0.70
|
MACOM is a real AI-connectivity enabler with scarce RF/photonics process know-how, qualified customer positions and enough internal manufacturing control to compound revenue well above a normal analog peer; the stock case works if 1.6T/3.2T optics, copper links and defense ramps turn design activity into sustained shipments faster than valuation compresses.
|
| 104 |
NET
|
cloud
cybersecurity
enterprise
networking
software
|
Cloudflare, Inc.
|
1.8x
|
0.72
|
Cloudflare’s best 5-year path is becoming the policy, security, and execution layer for internet traffic and AI agents, not just a content-delivery vendor; that can drive strong revenue compounding, but shareholder returns are capped unless usage monetization and reliability keep pace with a still-premium starting valuation.
|
| 105 |
ETN
|
aerospace
automation
energy
hardware
|
Eaton Corporation plc
|
1.8x
|
0.74
|
Eaton is an AI-era electrical toll collector: as compute gets cheaper, reliable power delivery, protection, thermal interfaces and channel trust get scarcer, and Eaton already owns many of those choke points. The five-year upside comes from backlog conversion, data-center and grid mix, Boyd-enabled thermal content, modular system offers and a cleaner post-Mobility portfolio.
|
| 106 |
NTAP
|
cloud
cybersecurity
enterprise
hardware
software
|
NetApp, Inc.
|
1.8x
|
0.55
|
NetApp is a quality compounder: if it keeps turning ONTAP from a storage operating system into a trusted control layer for hybrid cloud, cyber recovery, and AI-era data workflows, revenue can outgrow the mature storage market and the stock can earn a modest rerating without needing a frontier-AI narrative.
|
| 107 |
GOOG
|
advertising
ai
cloud
enterprise
media
|
Alphabet Inc.
|
1.8x
|
0.80
|
Alphabet looks like a high-quality AI-era compounder: it owns mass consumer distribution, hyperscale compute, and growing enterprise trust layers, so even if AI changes interfaces, much of the value can still be recaptured through Search, YouTube, Cloud, subscriptions, and newer action-oriented monetization.
|
| 108 |
PWR
|
cloud
communications
energy
|
Quanta Services, Inc.
|
1.8x
|
0.68
|
Quanta is a scarce execution layer for the AI-era power buildout: as electricity demand, grid complexity and large-load projects rise, it should capture outsized value through labor scale, customer embed, prefab and supply-chain control, though the stock already discounts part of that scarcity.
|
| 109 |
TLN
|
ai
energy
nuclear
|
Talen Energy Corporation
|
1.8x
|
0.68
|
Talen can compound by turning scarce PJM nuclear-and-gas capacity into more contracted, AI-load-linked cash flow while using free cash flow to absorb acquisition leverage; the upside is not software hypergrowth, but a rerating from merchant generator to scarce compute-enablement infrastructure.
|
| 110 |
CRWD
|
ai
cloud
cybersecurity
enterprise
software
|
CrowdStrike Holdings, Inc.
|
1.7x
|
0.70
|
CrowdStrike should remain an AI-era cyber winner because AI expands the attack surface, machine identities, logs, and response workload while Falcon’s shared telemetry, single-agent deployment, and Flex procurement model deepen wallet share; the constraint is that a premium valuation and lingering trust overhang make value capture, not demand, the key debate.
|
| 111 |
CEG
|
ai
energy
enterprise
nuclear
|
Constellation Energy Corporation
|
1.7x
|
0.80
|
Constellation owns scarce 24/7 clean and dispatchable power, grid-ready sites, and customer relationships just as AI load makes reliable electricity the bottleneck; that supports solid five-year value creation, but from execution and contract monetization more than from another dramatic rerating.
|
| 112 |
VST
|
automation
energy
nuclear
|
Vistra Corp.
|
1.7x
|
0.72
|
Vistra can compound equity at a low-to-mid teens rate by turning scarce nuclear and dispatchable gas capacity into longer-duration, compute-linked contracted cash flow, adding Cogentrix scale, and using stronger credit plus buybacks to shift the story from merchant generator toward scarce power infrastructure.
|
| 113 |
BWXT
|
aerospace
defense
energy
healthcare
nuclear
|
BWX Technologies, Inc.
|
1.7x
|
0.74
|
BWXT owns scarce, regulated nuclear capacity and trusted program positions that should grow with naval propulsion, defense fuels and commercial nuclear services, but value capture is still constrained by appropriations, licensing and plant throughput, so the next five years look like strong business compounding rather than explosive equity upside.
|
| 114 |
VRT
|
ai
automation
communications
enterprise
hardware
|
Vertiv Holdings Co
|
1.7x
|
0.78
|
Vertiv is a premium AI-infrastructure toll road: if it keeps converting backlog into faster-to-deploy power and cooling systems while lifting service and software-adjacent attach, revenue can compound hard through 2031, but shareholder returns should be solid rather than explosive because the stock already reflects scarcity economics.
|
| 115 |
ASML
|
ai
hardware
semiconductors
software
|
ASML Holding N.V.
|
1.6x
|
0.86
|
ASML should keep compounding because AI expands demand for the most advanced chips, and ASML owns the lithography bottleneck those chips require; High-NA, services and trusted software can lift revenue materially, but the stock is more likely to be a premium compounder than a massive rerating because much of that scarcity is already recognized.
|
| 116 |
STEM
|
ai
automation
energy
enterprise
software
|
Stem, Inc.
|
1.6x
|
0.50
|
Stem is a real embedded operating stack for renewable fleets; if it keeps converting installed-base workflow control into recurring software, managed services, and higher-trust outcome modules while getting through the 2030 debt wall without punitive dilution, modest enterprise-value growth can still produce a multi-bagger equity outcome by 2031.
|
| 117 |
LITE
|
ai
communications
hardware
networking
semiconductors
|
Lumentum Holdings Inc.
|
1.6x
|
0.70
|
Lumentum controls a real AI-era bottleneck in qualified optical capacity and can more than double revenue by 2031, but from a rerated starting valuation most shareholder upside depends on turning today’s scarcity into durable systems content, pricing power, and higher-value workflow attachment rather than on another major multiple expansion.
|
| 118 |
EQIX
|
ai
cloud
enterprise
networking
software
|
Equinix, Inc.
|
1.5x
|
0.80
|
Equinix should keep compounding as AI raises the value of scarce metro power, neutral interconnection and trusted private distribution; upside can improve through reservation-rights products, sovereign deployments and software attach, but power, permitting and heavy build spend keep the equity in premium-compounder territory rather than true hypergrowth.
|
| 119 |
HPE
|
ai
cloud
enterprise
hardware
networking
|
Hewlett Packard Enterprise Company
|
1.5x
|
0.48
|
HPE can outperform a normal hardware vendor if Juniper lifts networking mix, GreenLake becomes a deeper trust-and-operations layer, and enterprise AI backlog converts without margin damage; the upside is a better-quality infrastructure compounder with only modest rerating, not a fantasy software transformation.
|
| 120 |
NEE
|
ai
energy
nuclear
|
NextEra Energy, Inc.
|
1.4x
|
0.74
|
NextEra should be one of the clearest AI-power beneficiaries among regulated utilities because it owns Florida load growth, ready-to-build power sites and a scaled financing engine; but because value capture still runs through regulators, capex and dilution, shareholders are more likely to get premium compounding than explosive upside.
|